US Patent Issued to Novocure on Oct. 20 for "Changing the orientation of tumor treating fields (TTFields) by adjusting the amplitudes of two or more electric fields that are all in-phase with each other" (Israeli Inventors)

ALEXANDRIA, Va., Oct. 21 -- United States Patent no. 12,766,320, issued on Oct. 20, was assigned to Novocure GmbH (Baar, Switzerland).

"Changing the orientation of tumor treating fields (TTFields) by adjusting the amplitudes of two or more electric fields that are all in-phase with each other" was invented by Michael Modilevsky (Haifa, Israel), Yevgeniy Telepinsky (Haifa, Israel) and Michael Krinitsky (Haifa, Israel).

According to the abstract* released by the U.S. Patent & Trademark Office: "Tumor Treating Fields (TTFields) therapy is a proven approach for treating tumors using alternating electric fields. When treating tumors in certain anatomic locations (e.g., at certain locations within a subject's head) it may be beneficial to induc...